Measuring brain blood flow with light and MRI
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study uses a special light-based device and MRI to measure how blood vessels in the brain respond to changes. It may help researchers better understand blood flow in people with and without sickle cell disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 70 years old.
- You can have an MRI scan without needing sedation.
- You may have sickle cell disease (HbSS or beta thalassemia null) or be healthy.
- You do not have significant facial or skull deformities.
- You have no metal in or on your body that would make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an MRI scan to measure how your brain uses oxygen. It includes healthy participants and people with sickle cell disease or who previously needed ECMO, which may help researchers understand brain oxygen problems and how to monitor them.
This study uses MRI scans to understand how the brain and blood vessels are affected in children with sickle cell disease, including before and after certain treatments. It also includes healthy children for comparison and may help improve future monitoring and care.
This study measures how well blood flows through brain arteries in children with sickle cell disease using a noninvasive ultrasound test. It may help doctors better understand stroke risk and how treatments like hydroxyurea or recent care affect blood flow.
This study looks at how blood vessel function in the fingers (using a simple test called arterial tonometry) relates to thinking and memory in people with sickle cell disease. It involves a non-invasive measurement and cognitive tasks.
This study tests whether shining a special light on the head (called transcranial photobiomodulation) can help children with sickle cell disease. It aims to improve blood flow and reduce brain damage.
This study uses a PET scan to look for links between abnormal heart “filling” problems and how well blood reaches the heart muscle in people with sickle cell disease. The results may help explain early heart changes in sickle cell and guide future care.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.